GI & Endoscopy

Independent group purchasing organization Gastrologix entered into a pair of partnerships to provide more options to its independent gastroenterologist members.

Mercyhealth has hired Raza Hamdani, MD, to its staff at the Mercyhealth Rockton Avenue location in Rockford, Ill., according to the Rockford Register Star.

Johnson & Johnson Innovation invested about $8.4 million in medical device company Mauna Kea Technologies, acquiring 5.3 million shares.

Three gastroenterologists to know this week:

New research showed that liquid chemical sterilization and double high-level disinfection are equally effective at reprocessing duodenoscopes, but still left low rates of positive cultures, Gastroenterology & Endoscopy News reports.

RedHill Biopharma terminated its agreement with Salix Pharmaceuticals, regaining the exclusive rights to RHB-106, an encapsulated bowel preparation therapy.

Here are three updates from gastroenterology companies and practices from the past week:

The FDA accepted Pfizer's supplemental New Drug Application for its combination therapy for advanced BRAF-mutant metastatic colorectal cancer and granted it priority review designation.

Here are five must-read GI articles on Becker's ASC Review this week:

Check-Cap reported final results from its U.S. pilot study of its C-Scan System, a preparation-free colorectal cancer detection system.